Ironwood Pharmaceuticals Inc (IRWD)

IRWD (NASDAQ:Drugs)
$14.17
pos +0.36
+2.61%
Today's Range: 13.77 - 14.20 | IRWD Avg Daily Volume: 1,156,700
Last Update: 11/26/14 - 4:00 PM EST
Volume: 405,903
YTD Performance: 18.95%
Open: $13.79
Previous Close: $13.81
52 Week Range: $9.01 - $15.95
Oustanding Shares: 139,632,407
Market Cap: 1,704,423,906
6-Month Chart
TheStreet Ratings Grade for IRWD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 3 4 5
Moderate Buy 0 0 0 0
Hold 3 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 2 1 1 1
Mean Rec. 2.75 2.50 2.33 2.20
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -8.95
Price Earnings Comparisons:
IRWD Sector Avg. S&P 500
-8.95 0.00 26.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.69% 24.30% 27.87%
GROWTH 12 Mo 3 Yr CAGR
Revenue -84.80 -0.48 -0.19
Net Income 0.00 3.84 0.00
EPS 0.00 2.98 0.00
Earnings for IRWD:
EBITDA -0.25B
Revenue 0.02B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $-0.16 $-0.20 $-1.26 $-0.56
Number of Analysts 6 2 6 6
High Estimate $0.07 $-0.18 $-0.96 $-0.19
Low Estimate $-0.25 $-0.22 $-1.36 $-0.87
Prior Year $-0.43 $-0.38 $-2.35 $-1.26
Growth Rate (Year over Year) 63.57% 47.37% 46.17% 55.47%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bearish
Nov 06, 2014 | 6:54 AM EST
IRWD was downgraded from Hold to Sell, Cantor Fitzgerald said. $10 price target. Valuation call, as the company will likely spend more ...
Bullish
Jul 24, 2013 | 7:51 AM EDT
IRWD was upgraded to Hold, Cantor Fitzgerald said. $10 price target. Linzess can continue to grow and the company is keeping a tight li...
Bullish
May 30, 2013 | 8:09 AM EDT
IRWD was upgraded from Underperform to Neutral, Wedbush said. $12 price target. Linzess prescriptions are growing.
The negative surprises indicate hidden weakness in a business, and the stocks are to be avoided.
Bearish
Apr 24, 2013 | 8:17 AM EDT
Shares of IRWD were downgraded to Underperform  from Neutral, said Wedbush. Cash burn is occurring much faster than expected given...
Bullish
Mar 15, 2013 | 8:18 AM EDT
IRWD was upgraded to Outperform, Credit Suisse said. $24 price target. Expect higher Linzess sales. 
Bullish
Feb 13, 2013 | 8:38 AM EST
IRWD was upgraded to Neutral from Underperform, Wedbush said. $13 price target. LINZESS strong out of the gates. 
Bearish
Jan 16, 2013 | 8:39 AM EST
IRWD was downgraded to Sell from Neutral, UBS said. $11.50 price target. Expectations too high. 
Bearish
Mar 05, 2012 | 8:19 AM EST
IRWD was downgraded to Underperform from Outperform, Wedbush said.  $8 price target.  Updated launch expenses leads to signif...
Bearish
Feb 29, 2012 | 7:15 AM EST
IRWD was downgraded to Sell, Cantor Fitzgerald said. Valuation call, based on a $10 price target.

Columnist Conversations

Lang:
Lights, Camera, ACTION! This move lately in GPRO has been stellar, up nearly 12% over the past couple of sess...
For just under two weeks MCD has been bumping up against a very solid wall of resistance. The $96.95 to ...
Texas Instruments is surging today. Shares are up over 2.7% and are moving further into new 52W high gro...
Shares of Amazon (AMZN) have been trading within a set of Fibonacci retracements measured off their 2014 range...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.